NIDDK's Private Powwow: Funding Kidney Disease Breakthroughs
Published Date: 3/26/2025
Notice
Summary
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed virtual meeting from June 24-26, 2025, to review grant applications related to kidney, urologic, and blood diseases. This meeting affects researchers seeking funding and keeps sensitive information private. No money changes are announced, but the review helps decide who gets research support.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Closed NIH Grant Review Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases will hold a closed virtual meeting from June 24-26, 2025 (5 p.m. to 5 p.m.) to review and evaluate grant applications for kidney, urologic, and hematologic diseases. The meeting is closed to the public and will keep confidential trade secrets, patentable material, and personal information private. No money changes are announced in this notice, but the review helps decide who gets research support.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10814 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-05065 — Importer of Controlled Substances Application: Maridose LLC (I)
Maridose LLC wants to become an official importer of certain controlled substances. This means they’ll be allowed to bring in specific drugs that are carefully regulated. If approved, this could affect businesses and regulators keeping an eye on drug imports, with timing and costs tied to the registration process.
Next: 2025-05067 — National Center for Advancing Translational Sciences; Notice of Meeting
The National Center for Advancing Translational Sciences is holding a closed meeting on April 17, 2025, to review and decide on grant applications. This affects researchers seeking funding, as their proposals will be carefully evaluated behind closed doors to protect privacy and trade secrets. If you want to share your thoughts, you have 15 days after the meeting to send in comments.